Today: 26 January 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Intel Stock Outlook December 2025: AI Wafers Shortage, Tata Deal and U.S. Government Stake Reshape INTC

Intel Stock Outlook December 2025: AI Wafers Shortage, Tata Deal and U.S. Government Stake Reshape INTC

Intel Corporation (NASDAQ: INTC) has quietly become one of 2025’s most dramatic comeback stories. After losing nearly $19 billion in 2024, the chipmaker has returned to profitability, installed a new CEO, secured multibillion‑dollar backing from the U.S. government, SoftBank and Nvidia, and ridden the AI‑PC wave to a triple‑digit share‑price gain. NVIDIA Newsroom As of midday on December 9, 2025,…
9 December 2025
····
Confluent (CFLT) Stock Surges on IBM’s $11 Billion Takeover – What the $31 Cash Offer Means for Investors on December 9, 2025

Confluent (CFLT) Stock Surges on IBM’s $11 Billion Takeover – What the $31 Cash Offer Means for Investors on December 9, 2025

Updated: December 9, 2025 Key takeaways Important: This article is for information and news purposes only and is not investment advice. Confluent stock today: trading near the IBM offer As of mid‑day on December 9, 2025, Confluent, Inc. (NASDAQ: CFLT) is trading around $29.87 per share, almost flat versus Monday’s close after a dramatic one‑day move. StockAnalysis That price matters…
9 December 2025
····
JioHotstar Nears Netflix as JioStar Hires Debasmita Ghosh and Bets $444 Million on South Indian Content

JioHotstar Nears Netflix as JioStar Hires Debasmita Ghosh and Bets $444 Million on South Indian Content

New Delhi/Mumbai, December 9, 2025 — India’s streaming war has entered a new phase. JioStar, the Reliance–Disney joint venture behind JioHotstar, has appointed seasoned digital media leader Debasmita Ghosh as Vice President – Agency Business, just as JioHotstar closes in on Netflix’s global subscriber tally and unveils an aggressive, $444 million push into South Indian content. afaqs! Together, these moves…
9 December 2025
··
Warner Bros. Discovery (WBD) Stock Today: Paramount’s $108 Billion Hostile Bid, Netflix Deal Risk and 2026–2050 Forecasts

Warner Bros. Discovery (WBD) Stock Today: Paramount’s $108 Billion Hostile Bid, Netflix Deal Risk and 2026–2050 Forecasts

Date: December 9, 2025 Quick Take 1. What Is Warner Bros. Discovery, Inc. Series A Stock (WBD)? Warner Bros. Discovery, Inc. is a global media and entertainment company spanning film, TV, streaming and gaming, with brands such as Warner Bros., DC, HBO, Max, Discovery Channel, CNN, TNT Sports and others. Yahoo Finance Its publicly traded Series A common stock trades…
9 December 2025
····
Micron (MU) Stock Today: HSBC’s New $330 Target, AI Memory Supercycle and What Comes Next After a 170%+ Rally

Micron (MU) Stock Today: HSBC’s New $330 Target, AI Memory Supercycle and What Comes Next After a 170%+ Rally

Micron Technology, Inc. (NASDAQ: MU) is back in the spotlight on December 9, 2025, as a wave of fresh analyst upgrades collides with a powerful AI-driven memory boom. HSBC has just initiated coverage with a “Buy” rating and a $330 price target, implying sizable upside from Micron’s already‑elevated share price. 24/7 Wall St. At the same time, Micron is reshaping…
9 December 2025
····
Oracle Stock (ORCL) Today: AI Backlog, Debt Jitters and Q2 FY 2026 Earnings Preview for December 9, 2025

Oracle Stock (ORCL) Today: AI Backlog, Debt Jitters and Q2 FY 2026 Earnings Preview for December 9, 2025

Oracle Corporation (NYSE: ORCL) goes into its next earnings report as one of the most controversial names in big tech: a company sitting on a massive AI cloud backlog and multi‑hundred‑billion‑dollar contracts, but also rising debt, negative free cash flow and growing skepticism in credit and options markets. As of mid‑day on December 9, 2025, Oracle shares trade around $221,…
9 December 2025
···
Palantir (PLTR) Stock on December 9, 2025: Latest News, Analyst Forecasts, and High‑Stakes AI Growth Story

Palantir (PLTR) Stock on December 9, 2025: Latest News, Analyst Forecasts, and High‑Stakes AI Growth Story

Palantir Technologies Inc. (NASDAQ: PLTR) remains one of 2025’s most polarizing AI stocks. As of the close on December 8, 2025, Palantir shares changed hands at $181.49, down a modest 0.15% on the day but up more than 156% over the past 12 months. The stock has traded between $63.40 and $207.52 over the last year, with an average daily…
9 December 2025
····
Carvana (CVNA) Soars Toward S&P 500 Debut – Is the 8,000% Rally Still Sustainable in 2025?

Carvana (CVNA) Soars Toward S&P 500 Debut – Is the 8,000% Rally Still Sustainable in 2025?

Carvana Co. (NYSE: CVNA) has gone from near‑bankruptcy fears to S&P 500 inclusion in just three years, and its stock is trading near record highs as of 9 December 2025. Shares closed at $447.98 on 8 December, up about 12% in a single session and roughly doubling so far in 2025. StockAnalysis The online used‑car retailer’s market value has exploded…
9 December 2025
····
AMD Stock Today (December 9, 2025): AI Supercycle Hopes, China Export Breakthrough and What Wall Street Expects Next

AMD Stock Today (December 9, 2025): AI Supercycle Hopes, China Export Breakthrough and What Wall Street Expects Next

Advanced Micro Devices (NASDAQ: AMD) is back in the spotlight as fresh AI goals, changing U.S.–China export rules and a wave of bullish analyst calls collide. Here’s what’s really driving AMD stock on December 9, 2025. AMD stock on 09.12.2025: where things stand As of the latest trade data, AMD shares are changing hands around $221–224, after closing at $221.11…
9 December 2025
····
Alphabet (GOOG) Stock on December 9, 2025: EU AI Probe, Antitrust Ruling and $400 Price Targets

Alphabet (GOOG) Stock on December 9, 2025: EU AI Probe, Antitrust Ruling and $400 Price Targets

Alphabet Inc.’s Class C shares (NASDAQ: GOOG) are trading lower on Tuesday as investors digest a fresh wave of regulatory actions in both Europe and the United States—just weeks after the Google parent delivered a record quarter and as Wall Street pushes price targets as high as $400. This article looks at Alphabet Class C stock today, the latest news…
9 December 2025
···
Record $60,000 Seed Law Fine for North Dakota Farmer Puts ‘Seed Piracy’ and Plant Variety Protection Under the Microscope

Record $60,000 Seed Law Fine for North Dakota Farmer Puts ‘Seed Piracy’ and Plant Variety Protection Under the Microscope

What happened in Crystal, North Dakota? A routine regulatory audit has turned into a landmark case for U.S. seed law enforcement. According to a public notice from the North Dakota State Seed Department and reporting by Valley News Live, a farmer from Crystal, North Dakota, identified as Thomas Shephard, has paid $60,000 in penalties for multiple violations of state and…
9 December 2025
Amazon (AMZN) Stock on December 9, 2025: AI Capex Bets, Q3 Earnings and Wall Street’s 2026 Price Targets

Amazon (AMZN) Stock on December 9, 2025: AI Capex Bets, Q3 Earnings and Wall Street’s 2026 Price Targets

Amazon.com, Inc. (NASDAQ: AMZN) is back in focus as investors weigh massive artificial‑intelligence spending against reaccelerating cloud growth and a wave of fresh analyst forecasts. On December 9, 2025, new headlines touch everything from advanced battery technology to institutional buying, giving traders fresh data points heading into year‑end. Amazon stock today: price, range and recent performance Amazon shares closed Monday,…
9 December 2025
··
1 … 694 695 696 697 698 … 827

Stock Market Today

  • Sarepta Therapeutics Faces Biotech Headwinds Amid Potential Upside
    January 26, 2026, 8:22 AM EST. Sarepta Therapeutics (NASDAQ: SRPT) operates in rare disease biotech, focusing on Duchenne muscular dystrophy treatments with drugs like EXONDYS 51. Its stock trades near $21.13, after a wide 52-week range of $11.93 to $119.02, reflecting sector volatility. Despite a 14.5% revenue decline and negative earnings per share (-2.83), the forward price-to-earnings ratio of 6.77 indicates some expected profitability. Analyst ratings are mixed; 7 buy, 14 hold, and 5 sell, with an average target price slightly below current levels. Technical indicators show the stock close to oversold levels, suggesting a possible entry point for investors. Sarepta's future hinges on its drug pipeline and strategic partnerships as it navigates financial pressures common in biotech firms investing heavily in research and development.
Go toTop